Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M171,806Revenue $M44,033Net Margin (%)10.0Z-Score3.0
Enterprise Value $M182,030EPS $1.5Operating Margin %14.4F-Score4
P/E(ttm))38.9Cash Flow Per Share $6.3Pre-tax Margin (%)12.6Higher ROA y-yN
Price/Book3.410-y EBITDA Growth Rate %3.1Quick Ratio1.6Cash flow > EarningsY
Price/Sales4.05-y EBITDA Growth Rate %-6.3Current Ratio1.8Lower Leverage y-yN
Price/Cash Flow7.1y-y EBITDA Growth Rate %-6.6ROA % (ttm)4.2Higher Current Ratio y-yN
Dividend Yield %3.0Insider Buy (3m)0ROE % (ttm)8.9Less Shares Outstanding y-yY
Payout Ratio %115Shares Outstanding M2,922ROI % (ttm)6.0Gross Margin Increase y-yN

Gurus Latest Trades with MRK

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MRKJean-Marie Eveillard 2014-03-31 Add0.34%$49.49 - $57.47
($54.09)
$ 58.588%Add 15820.6%2,236,839
MRKDavid Dreman 2014-03-31 Buy 0.02%$49.49 - $57.47
($54.09)
$ 58.588%New holding, 4431 sh.4,431
MRKJoel Greenblatt 2014-03-31 Buy $49.49 - $57.47
($54.09)
$ 58.588%New holding, 3567 sh.3,567
MRKJames Barrow 2014-03-31 Reduce-0.48%$49.49 - $57.47
($54.09)
$ 58.588%Reduce -22.72%22,739,030
MRKDodge & Cox 2014-03-31 Reduce-0.45%$49.49 - $57.47
($54.09)
$ 58.588%Reduce -18.11%39,959,196
MRKVanguard Health Care Fund 2014-03-31 Reduce-0.15%$49.49 - $57.47
($54)
$ 58.588%Reduce -2.58%35,616,848
MRKGeorge Soros 2014-03-31 Sold Out -0.06%$49.49 - $57.47
($54.09)
$ 58.588%Sold Out0
MRKJohn Hussman 2014-03-31 Sold Out -0.01%$49.49 - $57.47
($54)
$ 58.588%Sold Out0
MRKGeorge Soros 2013-12-31 Buy 0.06%$45.09 - $50.18
($47.86)
$ 58.5822%New holding, 150000 sh.150,000
MRKRuane Cunniff 2013-12-31 Buy $45.09 - $50.18
($47.86)
$ 58.5822%New holding, 4075 sh.4,075
MRKJean-Marie Eveillard 2013-12-31 Reduce-0.16%$45.09 - $50.18
($47.86)
$ 58.5822%Reduce -98.76%14,050
MRKLeon Cooperman 2013-12-31 Sold Out -0.15%$45.09 - $50.18
($47.86)
$ 58.5822%Sold Out0
MRKCharles Brandes 2013-12-31 Reduce-0.14%$45.09 - $50.18
($47.86)
$ 58.5822%Reduce -8.39%2,476,201
MRKJean-Marie Eveillard 2013-09-30 Reduce-0.16%$46.55 - $48.58
($47.88)
$ 58.5822%Reduce -49.6%1,134,041
MRKGeorge Soros 2013-09-30 Sold Out -0.13%$46.55 - $48.58
($47.88)
$ 58.5822%Sold Out0
MRKJoel Greenblatt 2013-09-30 Sold Out -0.05%$46.55 - $48.58
($47.88)
$ 58.5822%Sold Out0
MRKJames Barrow 2013-06-30 Add1.32%$44.35 - $49.44
($46.81)
$ 58.5825%Add 134.86%29,318,754
MRKCharles Brandes 2013-06-30 Add0.48%$44.35 - $49.44
($46.81)
$ 58.5825%Add 43.39%2,703,540
MRKGeorge Soros 2013-06-30 Buy 0.13%$44.35 - $49.44
($46.81)
$ 58.5825%New holding, 250000 sh.250,000
MRKJean-Marie Eveillard 2013-06-30 Add0.1%$44.35 - $49.44
($46.81)
$ 58.5825%Add 46.32%2,250,286
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MRK is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
MRK Jean-Marie Eveillard 2014-03-312,236,8390.080.34+15820.6%
MRK David Dreman 2014-03-314,43100.02New Buy
MRK Joel Greenblatt 2014-03-313,56700New Buy
MRK Ruane Cunniff 2014-03-314,40900+8.2%
MRK Prem Watsa 2014-03-3112,00000.05
MRK Charles Brandes 2014-03-312,451,1250.081.8-1.01%
MRK Vanguard Health Care Fund 2014-03-3135,616,8481.225.7-2.58%
MRK Mario Gabelli 2014-03-31160,3160.010.05-18.07%
MRK Dodge & Cox 2014-03-3139,959,1961.372.3-18.11%
MRK James Barrow 2014-03-3122,739,0300.781.8-22.72%
MRK George Soros 2014-03-31000Sold Out
MRK John Hussman 2014-03-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


MRK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
FRAZIER KENNETH CChairman, President & CEO 2014-07-10Sell9,987$58.03-0.1view
GRADDICK WEIR MIRIAN MExe V-P, HR 2014-07-07Sell180,047$59.16-2.01view
GRADDICK WEIR MIRIAN MExe V-P, HR 2014-07-07Sell180,047$59.16-2.01view
Deese Willie AExe V-P & Pres. MMD 2014-06-27Sell72,290$58.26-0.5view
FRAZIER KENNETH CChairman, President & CEO 2014-06-10Sell9,985$58.06-0.16view
Schechter Adam HEVP & Pres-Global Human Health 2014-05-14Sell10,527$55.913.68view
FRAZIER KENNETH CChairman, President & CEO 2014-05-09Sell10,220$555.4view
FRAZIER KENNETH CChairman, President & CEO 2014-04-10Sell10,047$57.241.28view
Kuhlik Bruce NExe V-P & Gen Counsel 2014-04-04Sell145,225$56.432.73view
Golestani ClarkEVP & Chief Info Officer 2014-02-14Sell5,990$55.474.51view

Press Releases about MRK :

    Quarterly/Annual Reports about MRK:

      News about mrk:

      Articles On GuruFocus.com
      UnitedHealth Group Up on Weak Day for the Dow Jul 17 2014 
      U.S. Markets Regain Losses from Last Week Jul 14 2014 
      Abner Herrman Is Increasing Position in the Pharmaceutical Sector Jul 11 2014 
      U.S. Equity Markets Continue to Hit New Highs Jun 15 2014 
      Auxier Asset Management's Auxier Report - First Quarter 2014 May 06 2014 
      Will Pfizer’s Q1 2014 Earnings Beat the Street on May 5, 2014? May 05 2014 
      Wrong Marketing Lesson by Big Pharma May 03 2014 
      Vanguard Health Care Fund's Top Quarterly Holdings Apr 30 2014 
      Bill Nygren Comments on Merck Apr 10 2014 
      Abbvie Inc. (ABBV) Dividend Stock Analysis Mar 21 2014 


      More From Other Websites
      Merck Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell... Jul 29 2014
      Stocks: Dow ends the day in positive territory Jul 28 2014
      Why the Fed could start raising rates sooner than you think Jul 28 2014
      Will Merck & Co. (MRK) Surprise This Earnings Season? Jul 28 2014
      What to Watch in The Day Ahead; Tuesday, July 29 Jul 28 2014
      Business events scheduled for Tuesday Jul 28 2014
      Business events scheduled for Tuesday Jul 28 2014
      Merck KGaA CEO Karl-Ludwig Kley and German Federal Economics Minister Sigmar Gabriel Commission... Jul 28 2014
      Merck CEO Karl-Ludwig Kley and German Federal Economics Minister Sigmar Gabriel Commission... Jul 28 2014
      Merck aims to hike revenues in China to 1 billion euro by 2018 Jul 26 2014
      Merck aims to hike revenues in China to 1 bln eur by 2018 Jul 26 2014
      Merck aims to hike revenues in China to 1 bln eur by 2018 Jul 26 2014
      Merck aims to hike revenues in China to one billion euro by 2018 Jul 26 2014
      Traders brace for summer's busiest week Jul 25 2014
      What to Watch in the Week Ahead and on Monday, July 28 Jul 25 2014
      Merck Cuts 600 Sales Reps as Part of its Ongoing Reorganization Jul 25 2014
      Merck Looks Overpriced Compared To This Sector Peer Jul 24 2014
      Gilead Sciences Q2 2014: All Is Good, More To Come At Medical Conferences Later This Year Jul 24 2014
      [video] Cramer's Mad Dash: GILD bounces Jul 24 2014

      Add Notes, Comments or Ask Questions

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK
      Email Hide